GRCE
NASDAQ
$2.43
Acasti Pharma Inc (GRCE)
Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company is headquartered in Princeton, New Jersey.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $6.03 (+148.15%)
Market Cap
$39M
P/B Ratio
0.63
Free Cash Flow Yield
-22.78%
Beta (5Y)
0.86
Price Chart
Valuation
Market Cap$39M
Forward P/E2.17
P/S197.75
P/B0.63
Profitability
EBITDA-$11M
EPS-$0.53
Financial Health
Free Cash Flow Yield-22.78%
Growth & Risk
FCF 5Y CAGR-9.14%
Beta (5Y)0.86
Sharpe Ratio-0.08